July 2017

High Field Cardiac MRI
A Case for Ultrahigh Field Cardiac Magnetic Resonance

For a new technology, high-field cardiac magnetic resonance (CMR; 3.0 T≤B 0 ≤7.0 T) has come a long way. Not only has the number of reports referencing clinical applications risen, 1,2  but prices for 3.0T systems have dropped almost 50% since the beginning of the millennium, and operational and service costs are virtually identical to those of 1.5T machines. New 3.0T installations make up about 25% of the total market share and are increasing at an annual growth rate of ≈10%. 

Low Field Cardiac MRI - A Compelling Case for Cardiac Magnetic Resonance's Future

Cardiac magnetic resonance (CMR) is arguably unmatched in its ability to evaluate cardiovascular structure and function, to characterize myocardial tissue by a wide variety of mechanisms, and to quantitatively assess blood flow and perfusion without the use of radiation or the need for invasive catheterization. CMR research and development continues at a rapid pace both in academia and by commercial vendors, and every year, new techniques are put forth that improve on existing applications and provide new capabilities that further expand the clinical utility of this powerful modality. 

The Translations Committee is excited to announce two new translated publications:

Korean: Standardized Protocols. Standardized cardiovascular magnetic resonance (CMR) protocols
  1. Dr. Kyongmin Sarah Beck, Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea 
Persian: Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update
  1. Dr.Zahra Alizadeh SaniRajai, Cardiovascular Medical & Research Center,Iran University of Medical Science
  2. Pouya NezafatiMashhad, University of Medical Science
  3. Mahya Masoomi, Mashhad University of Medical Science
  4. Bita Zargaran, Research Committee, faculty of medicine, Islamic Azad University, Mashhad branch, Mashhad, Iran
  5. Mohaddesh Behjati, Rajai Cardiovascular Medical & Research Center,Iran University of Medical Science

The Women in CMR Section invite both men and women to join our section.  The section is chaired by Dr. M. Barbara Srichai-Parsia and newly elected vice chair, Dr. Sophie Mavrogeni. The main aims of our group are to increase female participation in the field and to raise awareness of disparities in clinical and imaging presentation of cardiovascular diseases that affect women.
One of our targets this year is the improved organization of CMR research focused on cardiovascular disease in women. To fulfill this target, we believe that creating small working groups centered around specific areas in woman's heart disease will further promote both research and education in the field including the development of teaching webinars and creation of multicenter research studies.

The proposed working groups include:
1. Autoimmune rheumatic diseases
2. Peripartum cardiomyopathy
3. CMR in pregnancy
4. Coronary artery disease in women
5. Takotsubo disease
6. CMR in female carriers of dystrophinopathy
7. Cardio-oncology

We strongly believe that the development of these working groups within our section will further promote interaction, education and research among our SCMR MEMBERS, and encourage interested members to join. 

Dr. M. Barbara Srichai-Parsia
Dr. Sophie Mavrogeni


Recent articles published in the journal include:

Catch up on current Cases of the Week posted to the SCMR  website:
SCMR is looking for new case submissions. To submit a case please click here to review the process.
Quick Links
To Improve Cardiovascular Health by Advancing the Field of CMR